2017 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
06/19/17T2 Biosystems Chief Scientific Officer Tom Lowery to Present at BIO 2017 Convention
Panel to Discuss Use of Novel Diagnostic Technologies to Improve Patient Care and Aid in Management of Antimicrobials LEXINGTON, Mass., June 19, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that its chief scientific officer, Tom Lowery, Ph.D. is scheduled to present at the 2017 BIO International Convention in San Diego, CA as part of a session titled “Using Novel D... 
Printer Friendly Version
06/08/17T2 Biosystems to Present at the 2017 Marcum Microcap Conference
LEXINGTON, Mass., June 08, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that John McDonough, president and chief executive officer, and Darlene Deptula-Hicks, SVP and chief financial officer, are scheduled to attend and present at the 2017 Marcum Microcap Conference. The conference is being held June 15-16, 2017 at the Grand Hyatt Hotel in New York City. Manageme... 
Printer Friendly Version
06/07/17T2 Biosystems Announces New T2Sepsis Solution™ Clinical and Economic Results Presented by Leading Experts at ASM Microbe 2017 Conference
Clinical Experts Discuss T2BacteriaTM Early Experience and Potential Emergency Department Applications T2Candida® Panel Users Present Compelling Rationale for Adoption, Implementation Process, and the Positive Clinical and Economic Results LEXINGTON, Mass., June 07, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced new data on the company’s T2Sepsis Solution, which i... 
Printer Friendly Version
06/01/17Study Published in the Journal of Clinical Microbiology Highlights Detection of Lyme Disease-Causing Bacteria in Blood Using T2 Biosystems’ T2MR® Technology
Data show strong evidence that Lyme disease-causing bacteria exist in blood and that T2MR has superior sensitivity to conventional PCR methods for direct detection in blood. LEXINGTON, Mass., June 01, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that a new study, “T2 Magnetic Resonance-based Direct Detection of Three Lyme Disease-Related Borrelia Species in Whole B... 
Printer Friendly Version
05/30/17T2 Biosystems to Present at the Jefferies 2017 Global Healthcare Conference
LEXINGTON, Mass., May 30, 2017 (GLOBE NEWSWIRE) --  T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that John McDonough, president and chief executive officer, and Darlene Deptula-Hicks, SVP and chief financial officer are scheduled to attend and present at the Jefferies 2017 Global Healthcare Conference. The conference is being held June 6-9, 2017 at the Grand Hyatt Hotel in New York City. ... 
Printer Friendly Version
05/24/17T2 Biosystems Announces Presentations at ASM Microbe 2017 Conference
LEXINGTON, Mass., May 24, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced two Industry & Science Showcases during the American Society for Microbiology (ASM) Microbe 2017 Conference in New Orleans, LA., June 1-5. Additionally, there will be several Sessions and Poster Presentations focused on the positive impact of the T2 Magnetic Resonance (T2MR®) technology by T2... 
Printer Friendly Version
05/19/17Henry Ford Health System to Present Webinar on Positive Clinical Impact of T2 Biosystems’ T2Candida® Panel
Webinar to be hosted by Dr. George Alangaden, Senior Staff Physician Director, Henry Ford Hospital LEXINGTON, Mass., May 19, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc., (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic return to healthcare institutions, announced today the company, in collaboration with LabRoots, will host a webinar on May 22, 2017, beginning at 10:00 a.m. PT/1:00 p.m. ET. The webinar will be hosted... 
Printer Friendly Version
05/02/17T2 Biosystems Reports First Quarter 2017 Results and Corporate Update
LEXINGTON, Mass., May 02, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced operating highlights and financial results for the first quarter ended March 31, 2017. Recent Operational and First Quarter Performance Highlights: Secured commitments from new hospitals in the U.S. and Europe that will provide access to an estimated 30,000 additional patients annually considered to be at high risk for sepsis infections. Secured contracts with 2 hospitals: 1 in the U... 
Printer Friendly Version
05/01/17T2 Biosystems Names Darlene Deptula-Hicks as Chief Financial Officer
LEXINGTON, Mass., May 01, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that Darlene Deptula-Hicks has been named senior vice president and chief financial officer. Ms. Deptula-Hicks is an accomplished financial executive in the life sciences and medical technology industries and has nearly 30 years’ experience leading financial operations for both public and private companies. She brings a proven track record in financial strategy, capital raising, M&A, pro... 
Printer Friendly Version
04/24/17T2 Biosystems Announces 2017 First Quarter Financial and Operational Results Release and Conference Call Date
LEXINGTON, Mass., April 24, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that it will release its 2017 first quarter financial and operational results after the market closes on Tuesday, May 2, 2017. In conjunction with the release, the Company will host a conference call with the investment community at 4:30 p.m. Eastern Time on Tuesday, May 2, 2017, to discuss the financial results and other business developments. Interested parties may access the live call v... 
Printer Friendly Version
04/19/17T2 Biosystems to Host Symposium at 27th European Congress of Clinical Microbiology and Infectious Diseases
Speakers to review clinical and economic benefits of direct-from-whole-blood identification of sepsis pathogens LEXINGTON, Mass., April 19, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that the company will be hosting a special symposium highlighting the clinical and economic benefits of testing with the T2Candida® Panel and previewing the performance of the T2Bacteria™ Panel at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) ... 
Printer Friendly Version
03/28/17T2 Biosystems to Present at the Needham Healthcare Conference
LEXINGTON, Mass., March 28, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that John McDonough, president and chief executive officer, is scheduled to attend and present at the Needham Healthcare Conference on Wednesday, April 5, 2017 at 11:20am ET at the Westin New York Grand Central Hotel in New York City. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company’s website at www.t2biosyste... 
Printer Friendly Version
02/13/17T2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results
LEXINGTON, Mass., Feb. 13, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic return to healthcare institutions, today announced operating highlights and financial results for the fourth quarter and year ended December 31, 2016. Recent Operational and Fourth Quarter Performance Highlights: Secured commitments in the fourth quarter that will provide access to an estimated... 
Printer Friendly Version
02/06/17T2 Biosystems to Present at the Leerink Global Healthcare Conference
LEXINGTON, Mass., Feb. 06, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that John McDonough, president and chief executive officer, and Shawn Lynch, chief financial officer, are scheduled to attend and present at the Leerink Global Healthcare Conference on Wednesday, February 15, 2017 at 3:30pm ET at the Lotte New York Palace in New York City. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of t... 
Printer Friendly Version
02/03/17T2 Biosystems Announces 2016 Fourth Quarter and Full-Year Results Release and Conference Call Date
LEXINGTON, Mass., Feb. 03, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that it will release its 2016 fourth quarter and full-year financial results after the market closes on Monday, February 13, 2017.  In conjunction with the release, the Company will host a conference call with the investment community at 4:30 p.m. Eastern Time on Monday, February 13, 2017, to discuss the financial results and other business developments. Interested parties may access the li... 
Printer Friendly Version
01/30/17Study Published in the American Journal of Clinical Pathology Highlights Rapid Detection of Platelet Function Using T2MR® Technology
Study Shows T2MR’s Sensitive Detection of Platelet Function at Similar or Lower Platelet Counts than Traditional Tests  Paper Provides Novel Insight Into Platelet Biology Not Evident Using Plasma-Based Platelet Aggregation Tests LEXINGTON, Mass., Jan. 30, 2017 (GLOBE NEWSWIRE) --  T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced that a new study, “Rapid evaluation of platelet function with T2 magnetic resonanc... 
Printer Friendly Version
01/25/17T2 Biosystems to Host Webinar on the Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship
Webinar to be hosted by Dr. Michael A. Pfaller, Chief Medical Officer LEXINGTON, Mass., Jan. 25, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic return to healthcare institutions, announced today that the company, in collaboration with LabRoots, will host a webinar on January 31, 2017 beginning at 10:00 a.m. PT/1:00 p.m. ET. The webinar will examine the critical role of r... 
Printer Friendly Version
01/09/17T2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress
-- On Track to Meet or Exceed Commercial Guidance and Regulatory Timelines -- LEXINGTON, Mass., Jan. 09, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic return to healthcare institutions, today announced preliminary results for its 2016 fourth quarter. Fourth Quarter Preliminary Performance and Recent Operational Highlights: Secured commitments in the fourth quarter ... 
Printer Friendly Version
01/05/17T2 Biosystems, Inc. Announces $50M Credit Facility
-- Retiring Former Debt Facility; Significantly Decreases Near-Term Cash Needs -- LEXINGTON, Mass., Jan. 05, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products that improve patient health and deliver a strong economic return to healthcare institutions, today announced that it has entered into a $50 million debt facility agreement with CRG LP. The new facility consists of an initial draw of $40 million and the ability to borrow an ad... 
Printer Friendly Version